ヒト成長ホルモン(HGH)の世界市場2015-2019

◆英語タイトル:Global Human Growth Hormone Market 2015-2019
◆商品コード:IRTNTR4664
◆発行会社(リサーチ会社):Technavio
◆発行日:2014年11月26日
◆ページ数:87
◆レポート言語:英語
◆レポート形式:pdf
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥260,000見積依頼/購入/質問フォーム
Five UserUSD2,800 ⇒換算¥291,200見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD3,500 ⇒換算¥364,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、ヒト成長ホルモン(HGH)の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、ヒト成長ホルモン(HGH)の世界市場規模及び予測、市場シェア、地域別分析、主要国別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。
【レポートの概要】

About Human Growth Hormones
Growth hormone is a proteinaceous hormone consisting of 191 amino acid residues and is secreted by the anterior part of the pituitary gland. In children and adolescents, growth hormones are produced and secreted in high levels and promote linear growth. However, as an individual reaches the adult stage, its level starts declining and primarily perform anabolic functions. The direct activity of a human growth hormone, exerted via its interaction with the human growth hormone receptor, includes metabolic and anti-insulin activities.

TechNavio’s analysts forecast the Global Human Growth Hormone market to grow at a CAGR of 4.22 percent over the period 2014-2019.

[Covered in this Report]
This report covers the present scenario and the growth prospects of the Global Human Growth Hormone market for the period 2015-2019. To calculate the market size, the report considers revenue from the sales of innovator human growth hormone drugs and their technologies.
TechNavio’s report, Global Human Growth Hormone Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Human Growth Hormone market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key Regions]
• Americas
• APAC
• EMEA

[Key Vendors]
• F. Hoffmann-La Roche
• Merck Serono
• Novo Nordisk
• Pfizer

[Other Prominent Vendors]
• Anhui Anke Biotechnology (Group)
• BioPartners
• Eli Lilly
• Ferring Pharmaceuticals
• GeneScience Pharmaceuticals
• Ipsen
• LG Life Sciences
• Sandoz International
• Teva Pharmaceutical Industries

[Market Driver]
• Increased Demand for Human Growth Hormones
• For a full, detailed list, view our report

[Market Challenge]
• Intense Market Competition
• For a full, detailed list, view our report

[Market Trend]
• Advances in Technology
• For a full, detailed list, view our report

[Key Questions Answered in this Report]
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【レポートの目次】

01. Executive Summary

02.List of Abbreviations

03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05.Introduction

06.Human Growth Hormone
06.1.1 Introduction
06.1.2 Human Growth Hormone
06.1.3 Mechanism of Action
06.1.4 Growth Hormone Levels
06.1.5 Population Group
06.1.6 Growth Hormone Levels (ng/mL)
06.1.7 Growth Hormone Deficiency

07.Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis

08.Geographical Segmentation
08.1 Human Growth Hormone Market in Americas
08.1.1 Market Size and Forecast
08.2 Human Growth Hormone Market in EMEA Region
08.2.1 Market Size and Forecast
08.3 Human Growth Hormone Market in APAC Region
08.3.1 Market Size and Forecast

09.Key Leading Countries
09.1 US
09.2 Japan
09.3 Germany
09.4 Italy

10.Buying Criteria

11.Market Growth Drivers

12.Drivers and their Impact

13.Market Challenges

14.Impact of Drivers and Challenges

15.Market Trends

16.Trends and their Impact

17.Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Market Share Analysis 2014
17.2.1 Merck Serono
17.2.2 Pfizer
17.2.3 Novo Nordisk
17.2.4 F. Hoffmann-La Roche
17.3 Other Prominent Vendors

18.Key Vendor Analysis
18.1 F. Hoffmann-La Roche
18.1.1 Key Facts
18.1.2 Business Overview
18.1.3 Business Segmentation
18.1.4 Business Segmentation by Revenue 2012 and 2013
18.1.5 Geographical Segmentation by Revenue
18.1.6 Business Strategy
18.1.7 Key Information
18.1.8 SWOT Analysis
18.2 Merck Serono
18.2.1 Key Facts
18.2.2 Business Overview
18.2.3 Geographical Segmentation by Revenue 2013
18.2.4 Business Strategy
18.2.5 Recent Developments
18.2.6 SWOT Analysis
18.3 Novo Nordisk
18.3.1 Key Facts
18.3.2 Business Overview
18.3.3 Business Segmentation by Revenue 2013
18.3.4 Business Segmentation by Revenue 2012 and 2013
18.3.5 Sales by Geography
18.3.6 Business Strategy
18.3.7 Key Information
18.3.8 SWOT Analysis
18.4 Pfizer
18.4.1 Key Facts
18.4.2 Business Overview
18.4.3 Business Segmentation by Revenue 2013
18.4.4 Business Segmentation by Revenue 2012 and 2013
18.4.5 Geographical Segmentation by Revenue
18.4.6 Business Strategy
18.4.7 Key Developments
18.4.8 SWOT Analysis

19.Other Reports in this Series

[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: 3D Structure of Human Growth Hormone
Exhibit 3: UniProt Details for Human Growth Hormone
Exhibit 4: Regulation of Human Growth Hormone Secretion
Exhibit 5: Normal Growth Hormone Levels
Exhibit 6: Classification of Growth Hormone Deficiency by Age of Onset
Exhibit 7: Global Human Growth Hormone market 2014-2019 (US$ million)
Exhibit 8: NordiPenMate
Exhibit 9: Global Human Growth Hormone Market Segmentation by Geography 2014
Exhibit 10: Global Human Growth Hormone Market Segmentation by Geography 2019
Exhibit 11: Global Human Growth Hormone Market by Geography 2014-2019 (US$ million)
Exhibit 12: Global Human Growth Hormone Market by Geography 2014-2019
Exhibit 13: Global Human Growth Hormone Market Segmentation by Geography 2014-2019
Exhibit 14: YoY Growth Rate of Global Human Growth Hormone Market by Geography 2014-2019
Exhibit 15: Percentage Share of Global Human Growth Hormone Market by Geography 2014 and 2019
Exhibit 16: Human Growth Hormone Market in the Americas 2014-2019 (US$ million)
Exhibit 17: Human Growth Hormone Market in the EMEA Region 2014-2019 (US$ million)
Exhibit 18: Human Growth Hormone Market in the APAC Region 2014-2019 (US$ million)
Exhibit 19: NovoFine Needle
Exhibit 20: Market Share Comparison of Major Drugs 2014 H1
Exhibit 21: Parts of Click.easy
Exhibit 22: Easypod Drug Delivery Device
Exhibit 23: Parts of Cool.click 2
Exhibit 24: One.click Drug Delivery Device
Exhibit 25: Serojet Drug Delivery Device
Exhibit 26: Genotropin Miniquick
Exhibit 27: Parts of Genotropin Miniquick
Exhibit 28: Genotropin Mixer
Exhibit 29: Parts of Genotropin Mixer
Exhibit 30: Genotropin Pen
Exhibit 31: Parts of Genotropin Pen
Exhibit 32: Dosage Strengths of FlexPro
Exhibit 33: Dosage Strengths of NordiFlex
Exhibit 34: Dosage Strengths of Norditropin NordiLet
Exhibit 35: Dosage Strengths of Nordipen
Exhibit 36: Parts of Nordipen
Exhibit 37: Parts of Nutropin AQ NuSpin
Exhibit 38: Nutropin AQ NuSpin 20
Exhibit 39: Nutropin AQ NuSpin 10
Exhibit 40: F. Hoffmann-La Roche: Business Segmentation by Revenue 2013
Exhibit 41: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
Exhibit 42: F. Hoffmann-La Roche: Revenue of Pharmaceuticals Division by Geography 2013
Exhibit 43: F. Hoffmann-La Roche: Revenue of Diagnostics Division by Geography 2013
Exhibit 44: Merck Serono: Geographical Segmentation by Revenue 2013
Exhibit 45: Novo Nordisk A/S: Business Segmentation by Revenue 2013
Exhibit 46: Novo Nordisk A/S: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 47: Novo Nordisk A/S: Sales by Geography 2013
Exhibit 48: Pfizer: Business Segmentation by Revenue 2013
Exhibit 49: Pfizer: Business Segmentation by Revenue 2012 and 2013
Exhibit 50: Pfizer: Geographical Segmentation by Revenue 2013



【掲載企業】

F. Hoffmann-La Roche, Merck Serono, Novo Nordisk, Pfizer, Anhui Anke Biotechnology (Group), BioPartners, Eli Lilly, Ferring Pharmaceuticals, GeneScience Pharmaceuticals, Ipsen, LG Life Sciences, Sandoz International , Teva Pharmaceutical Industries

【レポートのキーワード】

ヒト成長ホルモン(HGH)、薬、技術

【リサーチ方法】

Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes Technavio Platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[ヒト成長ホルモン(HGH)の世界市場2015-2019]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆